• Ingen resultater fundet

Danish Cancer Society Symposium

N/A
N/A
Info
Hent
Protected

Academic year: 2022

Del "Danish Cancer Society Symposium"

Copied!
4
0
0

Indlæser.... (se fuldtekst nu)

Hele teksten

(1)

1

Danish Cancer Society Symposium Cervical cancer control at crossroads

Programme

Monday, 26 October 2015

13.00 - 15.30: Check-in/registration/poster set-up/sandwiches 15.30 - 15.45: Welcome/Elsebeth Lynge

Session 1: HPV vaccination. Evidence for prevention of cervical cancer, HPV- naive, HPV non-naive, vaccine-type, non-vaccine-type

Chair: Elsebeth Lynge

15.45 - 16.15: Susanne Krüger Kjær

Efficacy and real world effectiveness of Gardasil and Gardasil-9 16.15 - 16.30: Discussion

16.30 - 17.00: Jorma Paavonen

The efficacy rates between the quadrivalent and bivalent HPV vaccines against cervical intraepithelial neoplasia grade 3 are different

17.00 - 17.15: Discussion 17.15 - 17.30: Break

Session 2: HPV vaccination. Current practice and plans in the Nordic countries Chair: Joakim Dillner

17.30 - 18.00: Søren Brostrøm (presentation will be given by his colleague Bolette Søborg) HPV vaccination in Denmark. Current practice and plans

18.00 - 18.10: Discussion

18.10 - 18.40: Matti Lehtinen

HPV vaccination in Finland. Current practice and plans 18.40 - 18.50: Discussion

18.50 - 19.20: Lára Sigurdardóttir

Vaccination in Iceland. Current practices

(2)

2 19.20 - 19.30: Discussion

19.30 - 20.00: Poster session 20.00 - Informal dinner

Tuesday, 27 October 2015

Session 3: HPV vaccination. Current practice and plans in the Nordic countries Chair: Matti Lehtinen

08.00 - 08.20: Mari Nygård

HPV vaccination in Norway. Current practice and plans

08.20 - 08.40: Ivar Sønbø Kristiansen

Cost-effectiveness of HPV vaccination in Norway 08.40 - 08.55: Discussion

08.55 - 09.15: Miriam Elfström

HPV vaccination in Sweden. Current practice and evaluation of program efforts

09.15 - 09.30: Discussion

09.30 - 10.00: Poster session/break

Session 4: Cervical screening. Current practice in the Nordic countries Chair: Jesper Bonde

10.00 - 10.30: Joakim Dillner HPV-based screening

10.30 - 11.00: Björn Strander

Old and new guidelines for cervical screening in Sweden 11.00 - 11.15: Discussion

11.15 - 11.45: Ameli Tropé

Screening in Norway, experiences and plans

11.45 - 12.00: Kristján Oddsson

Cervical cancer prevention in Iceland for 50 years 12.00 - 13.00: Lunch with the speakers

(3)

3 Session 5: Cervical screening. Current practice in the Nordic countries

Chair: Björn Strander

13.00 - 13.30: Pekka Nieminen

Integrating the screening activity and HPV vaccination in Finland 13.30 - 13.45: Discussion

13.45 - 14.15: Carsten Rygaard

Practice and challenges in cervical screening in Denmark 14.15 - 14.30: Break

Session 6: Cervical screening. Current practice in the Nordic countries Chair: Iben Holten

14.30 - 15.00: Sven Törnberg Screening uptake

15.00 – 15.30: Jesper Bonde

Getting screening non-responders screened. Results and experiences from the now complete Copenhagen Self-sampling Initiative pilot implementation program

15.30 - 16.00: Bengt Andrae

Participation, screening method and clinical management. Are the guidelines optimal and do we follow them?

16.00 - 16.15: Break

Session 7: Monitoring and databases Chair: Tytti Sarkeala

16.15 - 16.45: Pär Sparén

Interplay between HPV vaccination and screening coverage

16.45 – 16.55: Miriam Elfström

Monitoring HPV vaccination. Evidence from a Europe-wide survey

16.55 - 17.15: Ahti Anttila

Monitoring cervical screening

17.15 - 17.30: Discussion, future data requirements 17.30 - 18.00: Break

18.00 - Dinner, poster prizes and surprise guest

(4)

4

Wednesday, 28 October 2015

08.30 - 09.00: Poster prize winners – Presentation of their posters Chair: Poster evaluation committee

Session 8: Trends in cervical cancer incidence Chair: Sven Törnberg

09.00 - 09.30: Stefan Lönnberg

Trends in cervical cancer, experiences and expectations

09.30 - 10.00: Matti Hakama

The bipolar age pattern of cervix cancer

10.00 - 10.30: Discussion, ”eradication” of cervical cancer incidence, short and long term perspective

10.30 - 10.45: Break

Session 9: Conclusions

Chair: Carsten Rygaard

10.45 - 11.15: Challenges in HPV vaccination, information and coverage Discussant: Joakim Dillner

11.15 - 11.45: Challenges in cervical screening, coverage and follow-up Discussant: Ameli Tropé

11.45 - 12.00: Messages from meeting 12.00 - Lunch available

Referencer

RELATEREDE DOKUMENTER

• Evaluate the current Nordic approval and acceptance practice for materials and products in contact with drinking water and identify the mechanism(s) that will increase innovation

During the 1970s, Danish mass media recurrently portrayed mass housing estates as signifiers of social problems in the otherwise increasingl affluent anish

Jacques Pouyssegur, France Lorenz Poellinger, Sweden Margaret Ashcroft, UK Marja Jäättelä, Denmark. Oluf Borbye Pedersen, Denmark Peter Friedl, the Netherlands Robert

Funded by: Danish Cancer Society | The Novo Nordisk

Joni Krekola fra Riksdagsbiblioteket i Finland og norske Rønnings interessante og formfuldendte undersøgelse af den internationale kadreuddannelse, der før krigen foregik

15:30–17:00 • AUDITORIUM CARDEAL MEDEIROS Chair: Adriana Martins, U Católica Portuguesa.. “Welcome and Opening Remarks,” Paula

The degree programme board decides which actions should be given priority in the plans of action for 2021 based on last year’s plans of action and the current status of the

The degree programme board decides which actions should be given priority in the plans of action for 2021 based on last year’s plans of action and the current status of the